Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 281.1M
Gross Profit 78.6M 27.98%
Operating Income -8.2M -2.90%
Net Income -7.5M -2.66%
EPS (Diluted) -$0.37

Balance Sheet Metrics

Total Assets 169.9M
Total Liabilities 73.2M
Shareholders Equity 96.7M
Debt to Equity 0.76

Cash Flow Metrics

Operating Cash Flow 4.3M
Free Cash Flow -194.0K

Revenue & Profitability Trend

PetMed Express Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 281.1M 256.6M 272.3M 303.6M 284.1M
Cost of Goods Sold 202.4M 185.8M 195.3M 219.3M 202.9M
Gross Profit 78.6M 70.7M 76.9M 84.3M 81.2M
Operating Expenses 79.8M 61.1M 49.9M 51.4M 48.0M
Operating Income -8.2M 6.1M 24.3M 30.5M 31.0M
Pre-tax Income -6.3M 7.4M 24.2M 31.0M 33.9M
Income Tax 1.2M 2.3M 5.5M 7.0M 8.0M
Net Income -7.5M 5.1M 18.7M 23.9M 25.9M
EPS (Diluted) -$0.37 $0.25 $1.04 $1.52 $1.29

Income Statement Trend

PetMed Express Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 93.6M 130.4M 151.0M 161.2M 129.0M
Non-Current Assets 76.2M 37.0M 28.7M 26.3M 26.3M
Total Assets 169.9M 167.5M 179.7M 187.5M 155.3M
Liabilities
Current Liabilities 72.2M 57.5M 56.2M 44.9M 24.3M
Non-Current Liabilities 995.0K 0 0 1.3M 970.0K
Total Liabilities 73.2M 57.5M 56.2M 46.2M 25.3M
Equity
Total Shareholders Equity 96.7M 110.0M 123.4M 141.3M 130.0M

Balance Sheet Composition

PetMed Express Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -7.5M 5.1M 18.7M 23.9M 25.9M
Operating Cash Flow 4.3M 24.8M 15.6M 32.9M 36.2M
Investing Activities
Capital Expenditures -4.5M -5.3M -1.8M -2.4M -2.3M
Investing Cash Flow -40.7M -10.3M -1.8M -2.4M -2.3M
Financing Activities
Dividends Paid -12.4M -24.5M -24.4M -22.7M -21.8M
Financing Cash Flow -12.4M -24.5M -24.4M -22.7M -33.3M
Free Cash Flow -194.0K 22.5M 16.7M 37.6M 36.5M

Cash Flow Trend

PetMed Express Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 326.00
Forward P/E -108.67
Price to Book 0.70
Price to Sales 0.27
PEG Ratio -108.67

Profitability Ratios

Profit Margin 0.15%
Operating Margin -0.85%
Return on Equity 0.36%
Return on Assets 0.93%

Financial Health

Current Ratio 1.43
Debt to Equity 1.15
Beta 0.81

Per Share Data

EPS (TTM) $0.01
Book Value per Share $4.66
Revenue per Share $12.02

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
pets 67.3M 326.00 0.70 0.36% 0.15% 1.15
Walgreens Boots 9.8B 27.10 1.38 -66.21% -3.80% 428.71
High Tide 180.6M -43.80 1.28 -6.69% -1.76% 44.69
Wellgistics Health 71.2M -6.13 13.58 -2,124.65% -135.22% 571.67
Scienture Holdings 12.1M 1.39 0.14 -35.92% 4.39% 4.70
China Jo-Jo 9.9M -0.37 0.47 -29.67% -3.80% 209.57

Financial data is updated regularly. All figures are in the company's reporting currency.